Neuraminidase Inhibitor class drugs

6 results

  • oseltamivir phosphate

    (Oseltamivir phosphate)
    Ajanta Pharma USA Inc.
    Oseltamivir phosphate for oral suspension is indicated for the treatment of acute, uncomplicated influenza A and B in patients aged 2 weeks and older, symptomatic for up to 48 hours, and for prophylaxis in patients 1 year and older. It's not a substitute for annual vaccination.
    Medication Details
    Drug Interactions

  • oseltamivir phosphate

    (Oseltamivir)
    AvKARE
    Oseltamivir phosphate capsules are indicated for treating acute, uncomplicated influenza A and B in patients aged 2 weeks and older symptomatic for no more than 48 hours, and for prophylaxis in those aged 1 year and older. It is not a substitute for annual influenza vaccination.
    Medication Details
    Drug Interactions

  • oseltamivir phosphate

    (Oseltamivir Phosphate)
    AvKARE
    Oseltamivir phosphate for oral suspension is indicated for treating uncomplicated influenza A and B in patients 2 weeks and older, symptomatic for no more than 48 hours, and for prophylaxis in individuals 1 year and older. It is not a substitute for annual influenza vaccination.
    Medication Details
    Drug Interactions

  • oseltamivir phosphate

    (Oseltamivir phosphate)
    MSN LABORATORIES PRIVATE LIMITED
    Oseltamivir phosphate capsules are indicated for treating acute, uncomplicated influenza A and B in patients aged 2 weeks and older, symptomatic for no more than 48 hours. They are also used for the prophylaxis of influenza in individuals 1 year and older. Annual vaccination is recommended.
    Medication Details
    Drug Interactions

  • oseltamivir phosphate

    (OSELTAMIVIR PHOSPHATE)
    Aurobindo Pharma Limited
    Oseltamivir phosphate oral suspension is indicated for treating acute, uncomplicated influenza A and B in patients 2 weeks and older symptomatic for no more than 48 hours, and for prophylaxis in patients 1 year and older. It is not a substitute for vaccination and may have effectiveness limitations.
    Medication Details
    Drug Interactions

  • tamiflu

    (oseltamivir phosphate)
    Genentech, Inc.
    TAMIFLU is indicated for treating acute, uncomplicated influenza A and B in patients 2 weeks and older within 48 hours of symptom onset, and for prophylaxis in those 1 year and older. It is not a substitute for vaccination and has limitations regarding resistance and specific patient populations.
    Medication Details
    Drug Interactions